Mon-Fri 8-16 (GMT +2)
By regularly testing PSA it's possible to detect early‑stage asymptomatic prostate cancer. The specialists at Docrates recommend that men of 50 to 75 years of age have their PSA level checked each year in a PSA testing.
By regularly testing PSA it’s possible to detect early‑stage asymptomatic prostate cancer. PSA (prostate-specific antigen) is a protein produced by the prostate. Its level in the blood typically increase in prostate cancer and benign prostatic hyperplasia. PSA level can be determined with a simple blood test.
The specialists at Docrates recommend that men of 50 to 75 years of age have their PSA level checked each year in a PSA testing. If close relatives have been diagnosed with cancer, monitoring and testing should begin even earlier. Regular PSA testing helps to assess the cancer risk and the need for any further examinations. Sometimes PCA3 determination can provide additional information.
The significance of the PSA level should always be assessed in proportion to the size of the prostate. The larger the prostate, the higher the PSA level. Even quite low PSA levels can indicate cancer. The level of free PSA is significant in differential diagnostics when assessing benign and malignant lesions. The lower the free PSA level, the higher the risk of cancer. The following table shows the reference values for total PSA in different age groups and the relationship between the percentage of free PSA and cancer risk.
The table below is intended as a rule of thumb for the assessment.
S-PSA ( µg/l )
less than 2,5
less than 3,5
less than 4,5
less than 6,5
Proportion of free PSA (%)
Cancer risk (%)
(Sources: Thompson et al.: Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter, New England Journal of Medicine, 2004, May 27, and Finnish Current Care guidelines)
There are as many reasons to choose a private cancer hospital as there are people. We compiled the reasons most...Read more
The coronavirus is a concern among cancer patients. We listed the most common concerns and the answers to them.Read more
Many cancer patients have several concerns when it comes to the coronavirus epidemic, e.g. how does the situation impact my...Read more
In addition to oncology, Jorma Sormunen has years of experience in occupational healthcare. He has personally witnessed how important work...Read more